Primer: Ganzhou Hemay Pharmaceutical (GHP HK) - Apr 2026
Ganzhou Hemay Pharmaceutical is a clinical-stage biopharmaceutical company with a strategic focus on the development of small molecule drugs...
94 Views
Pre-IPO Ganzhou Hemay Pharmaceutical - The Concerns on the Pipelines
Mufemilast, Hemay022 face challenges in commercialization due to uncertainties in R&D, fierce competition. As valuation logic for innovative drugs...
754 Views
No more insights